9 results
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Synjardy (metformin + empagliflozin ... Xigduo (metformin + dapagliflozin ... (linagliptin + empagliflozin ... ) • Qtern (dapagliflozin
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
inhibitors - Canagliflozin ... (Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
EMPA-REG OUTCOME - Empagliflozin ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin ... EMPEROR-REDUCED - Empagliflozin ... SGLT2 #inhibitors #EBM
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
gliflozin): • Empagliflozin ... the three • Dapagliflozin ... loss (~2-3kg) • Empagliflozin ... • Euglycemic diabetic ... #Summary #DM2 #diabetes
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
treatment of type II diabetes ... (Invokana®), dapagliflozin ... (Farxiga®) and empagliflozin ... , #dapagliflozin ... , #empagliflozin
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... those who received dapagliflozin ... or absence of diabetes ... Kosalan Akilan #Dapagliflozin ... visualabstract #ebm
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... • SGLT2i (Dapagliflozin ... sarahthelyon #Diabetes
Empagliflozin

#cardiology  #medstudent #empagliflozin  
By:Verma, S., Rawat, S., Ho, K. L., Wagg, C. S., Zhang,
Empagliflozin ... #medstudent #empagliflozin ... Empagliflozin Increases ... Production in Diabetes
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
compared to SGLT2 empagliflozin ... #semaglutide #Diabetes